Yuekang Pharmaceutical announced that recently, the company received the “Drug Supplement Application Approval Notice” for injectable cefumezole sodium approved and issued by the State Drug Administration. The drug passed the consistent evaluation of generic drug quality and efficacy. Injectable cefmetazole sodium is mainly suitable for treating infections caused by Staphylococcus aureus, Escherichia coli, pneumococcus, Proteus, Mormonella, Providence, Streptococcus spp., Bacillus spp., and Prevoracter spp.

Zhitongcaijing · 10/18 07:49
Yuekang Pharmaceutical announced that recently, the company received the “Drug Supplement Application Approval Notice” for injectable cefumezole sodium approved and issued by the State Drug Administration. The drug passed the consistent evaluation of generic drug quality and efficacy. Injectable cefmetazole sodium is mainly suitable for treating infections caused by Staphylococcus aureus, Escherichia coli, pneumococcus, Proteus, Mormonella, Providence, Streptococcus spp., Bacillus spp., and Prevoracter spp.